72.11.Z - Research and experimental development on biotechnology
58.11.Z - Book publishing
58.19.Z - Other publishing activities
63.11.Z - Data processing, hosting and related activities
71.20.A - Food quality testing and analysis
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
72.20.Z - Research and experimental development on social sciences and humanities
74.30.Z - Translation and interpretation activities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
2020 | 2021 | ||
---|---|---|---|
K PLN | K PLN | % | |
Assets | 115,1 | 136 | 18,1 |
Gross profit (loss) | 55,2 | -28,8 | -152,2 |
EBITDA | 55,2 | -28,8 | -152,1 |
Net profit (loss) | 54,8 | -28,8 | -152,6 |
Liabilities and provisions for liabilities | 121,3 | 171 | 41 |
Net income from sale | 182 | 326,2 | 79,2 |
Working assets | 0 | 0 | 0 |
Equity capital | -6,2 | -35 | -467,4 |
Operating profit (EBIT) | 55,2 | -28,8 | -152,1 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Equity capital to total assets | -5,4 | -25,8 | -20,4 |
Gross profit margin | 30,4 | -8,8 | -39,2 |
EBITDA Margin | 30,4 | -8,8 | -39,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane